Late Breaking Abstract - Metered Cryospray improves patient-reported outcome measures at 6-months post-treatment, in patients with COPD with chronic bronchitis, in a randomised, sham-controlled trial
C. Orton (London, United Kingdom), J. Tonkin (London, United Kingdom), L. Chan (London, United Kingdom), F. Conway (London, United Kingdom), A. Tana (London, United Kingdom), B. Vijayakumar (London, United Kingdom), J. Hartman (Groningen, Netherlands), C. Caneja (London, United Kingdom), L. Avanzi (London, United Kingdom), K. Klooster (Groningen, Netherlands), J. Thornton (London, United Kingdom), J. Robertus (London, United Kingdom), D. Slebos (Groningen, Netherlands), P. Bhavsar (London, United Kingdom), P. Shah (London, United Kingdom)
Source: International Congress 2022 – Practice changing pleural interventions and beyond in 2022
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Orton (London, United Kingdom), J. Tonkin (London, United Kingdom), L. Chan (London, United Kingdom), F. Conway (London, United Kingdom), A. Tana (London, United Kingdom), B. Vijayakumar (London, United Kingdom), J. Hartman (Groningen, Netherlands), C. Caneja (London, United Kingdom), L. Avanzi (London, United Kingdom), K. Klooster (Groningen, Netherlands), J. Thornton (London, United Kingdom), J. Robertus (London, United Kingdom), D. Slebos (Groningen, Netherlands), P. Bhavsar (London, United Kingdom), P. Shah (London, United Kingdom). Late Breaking Abstract - Metered Cryospray improves patient-reported outcome measures at 6-months post-treatment, in patients with COPD with chronic bronchitis, in a randomised, sham-controlled trial. 4172
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|